▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Cory Renauer

TMFang4apples

Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.

Recent Articles by Cory Renauer

individual-investor-looking-at-stock-charts-getty

Jan 9, 2024 by Cory Renauer

2 Unstoppable Dividend Stocks Yielding More Than 9% That Income-Seeking Investors Will Want to Buy in 2024 and Hold Forever

These companies' payouts are on steadier ground than you'd expect from stocks offering such high yields.

wall-street-analyst-with-laptop-getty

Jan 8, 2024 by Cory Renauer

2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street

Find out why investment bank analysts are hyperbullish for these stocks.

investment-presentation-getty

Jan 6, 2024 by Cory Renauer

Want an Extra $1,000 in Annual Dividend Income in 2024? Invest $13,670 in These Magnificent, High-Yield Dividend Stocks

These stocks are poised to deliver heaps of dividend income to patient investors.

two-people-use-devices-at-home-getty

Jan 5, 2024 by Cory Renauer

2 Biotech Stocks With Huge Catalysts in 2024

Important clinical-trial readouts on the way could send these stocks soaring in early 2024.

smart-investor-having-a-good-day-getty

Jan 2, 2024 by Cory Renauer

A Dow Jones Bull Market Is Here: 2 Dividend Stocks That Still Look Like Bargains

Find out if they're stocks you want to jump on right now.

investment-advisor-getty

Dec 31, 2023 by Cory Renauer

Eli Lilly Stock Jumped 59% in 2023. Is It a Good Stock to Buy in 2024?

Sales of its new weight-management drug could be off the charts next year.

investor-buying-growth-stocks-getty

Dec 31, 2023 by Cory Renauer

Warren Buffett Invested $25 Billion of His Portfolio in 2 Stocks That Could Rise 37% and 14% in 2024, According to a Pair of Wall Street Analysts

These stocks could outperform in 2024, according to the investment bank analysts who follow them.

investor-looking-for-stocks-getty

Dec 30, 2023 by Cory Renauer

2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right. Could They Be Smart Buys for You in 2024?

Unusually high dividend yields are typically a sign of trouble ahead, but billionaire investors are eager to buy these stocks, according to their latest disclosures.

warren-buffett-fool-may-2015

Dec 28, 2023 by Cory Renauer

Warren Buffett Dumped These 2 Top Dividend Stocks. Should You Follow His Lead?

Buffett didn't say why he closed positions in two stocks with underlying businesses that are doing well at the moment.

investor-stock-charts-laptop-getty

Dec 27, 2023 by Cory Renauer

3 Phenomenal High-Yield Dividend Stocks to Buy Hand Over Fist in 2024 and Hold Forever

A combination of high yields and the strong likelihood of dividend raises in the future make these compelling stocks ready to buy now.

investor-with-computer-getty

Dec 23, 2023 by Cory Renauer

Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?

The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.

a-person-delivering-a-presentation-getty

Dec 22, 2023 by Cory Renauer

Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?

The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.

investor-checking-stocks-getty

Dec 19, 2023 by Cory Renauer

3 Unstoppable Dividend-Growth Stocks You Can Buy Now and Hold Forever

These stocks have raised their payouts every year for decades and could keep doing so for the rest of your days.

individual-investor-devices-getty

Dec 19, 2023 by Cory Renauer

1 Incredible Stock on Its Way to Join Alphabet, Amazon, Apple, Microsoft, and Nvidia in the $1 Trillion Club in 2024

The holding company Warren Buffett has managed since 1965 is already most of the way there.

wall-street-analyst-getty

Dec 18, 2023 by Cory Renauer

2 High-Yield Dividend Stocks That Could Climb 29% and 24% in 2024, According to Wall Street.

These dividend payers offer attention-getting yields and a chance for significant growth of your principal investment.

TMF-warren-buffett-4-tmf-may-2014

Dec 17, 2023 by Cory Renauer

57.7% of Warren Buffett's $375 Billion Portfolio Is Invested in These 2 Dividend-Paying Stocks

Buffett's holding company, Berkshire Hathaway, doesn't pay a dividend itself, but its equity portfolio is chock-full of dividend-paying stocks.

sectional-sofa-investor-getty

Dec 16, 2023 by Cory Renauer

Want to Gain $1,000 of Annual Dividend Income in 2024? Invest $11,930 in These Unstoppable, High-Yield Dividend Stocks

With an average yield of 8.7% at recent prices, these high-yield dividend payers are hard to ignore.

device-investor-getty

Dec 14, 2023 by Cory Renauer

Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?

Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.

investor-looks-at-financial-chart-on-laptop-getty.

Dec 12, 2023 by Cory Renauer

A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street

There's a huge gap between what the stock market and Wall Street analysts have to say about this often-overlooked growth stock.

investor-stock-charts-screens-getty

Dec 11, 2023 by Cory Renauer

Is CRISPR Therapeutics a Good Stock to Buy Following Approval of Its First Drug?

A simultaneous pair of approvals from the U.S. Food and Drug Administration gives investors new factors to consider.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services